The introduction of AbbVie’s hepatitis C drugs in 2014 forced Gilead’s hand in the fight for market dominance in hepatitis C.

Shares of edtech unicorn PhysicsWallah Ltd on Tuesday listed with a premium of 33 per cent against the issue price of Rs ...

PhysicsWallah IPO Listing Today: PhysicsWallah shares are set to debut on the stock exchanges on November 18, with analysts ...

SFU Beedie’s online, part-time Graduate Diploma in Business Administration offers MBA-level learning with flexibility—and no GMAT requirement.